Susquehanna International Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.71M Sell
134,800
-78,500
-37% -$5.53M ﹤0.01% 3328
2025
Q4
$14.4M Sell
213,300
-184,500
-46% -$12.4M ﹤0.01% 2589
2025
Q3
$29.2M Buy
397,800
+199,000
+100% +$13.2M ﹤0.01% 1817
2025
Q2
$10.3M Buy
198,800
+30,400
+18% +$1.73M ﹤0.01% 2782
2025
Q1
$10.7M Sell
168,400
-81,800
-33% -$4.75M ﹤0.01% 2437
2024
Q4
$12M Buy
250,200
+131,700
+111% +$6.75M ﹤0.01% 2437
2024
Q3
$6.78M Buy
118,500
+46,500
+65% +$2.67M ﹤0.01% 3129
2024
Q2
$3.77M Sell
72,000
-19,200
-21% -$842K ﹤0.01% 3903
2024
Q1
$3.71M Sell
91,200
-20,900
-19% -$783K ﹤0.01% 4137
2023
Q4
$4.14M Sell
112,100
-29,300
-21% -$1.1M ﹤0.01% 4036
2023
Q3
$5.4M Buy
141,400
+5,800
+4% +$238K ﹤0.01% 3385
2023
Q2
$4.89M Sell
135,600
-32,900
-20% -$1.12M ﹤0.01% 3574
2023
Q1
$6.44M Sell
168,500
-13,500
-7% -$633K ﹤0.01% 3081
2022
Q4
$10.4M Buy
182,000
+23,300
+15% +$1.19M ﹤0.01% 2226
2022
Q3
$6.28M Buy
158,700
+68,200
+75% +$3.01M ﹤0.01% 2819
2022
Q2
$3.98M Sell
90,500
-82,000
-48% -$3.55M ﹤0.01% 3573
2022
Q1
$6.88M Buy
172,500
+58,600
+51% +$2.09M ﹤0.01% 3119
2021
Q4
$4.58M Sell
113,900
-63,700
-36% -$2.38M ﹤0.01% 3900
2021
Q3
$7.22M Sell
177,600
-17,700
-9% -$740K ﹤0.01% 3358
2021
Q2
$8.87M Buy
195,300
+33,600
+21% +$1.49M ﹤0.01% 3094
2021
Q1
$6.74M Sell
161,700
-42,100
-21% -$1.92M ﹤0.01% 3394
2020
Q4
$8.7M Buy
203,800
+106,100
+109% +$3.81M ﹤0.01% 2662
2020
Q3
$2.57M Sell
97,700
-55,900
-36% -$1.56M ﹤0.01% 4142
2020
Q2
$4.12M Buy
153,600
+36,200
+31% +$817K ﹤0.01% 3282
2020
Q1
$2.11M Sell
117,400
-223,600
-66% -$4.24M ﹤0.01% 3880
2019
Q4
$6.05M Buy
341,000
+7,000
+2% +$121K ﹤0.01% 2723
2019
Q3
$5.18M Sell
334,000
-10,600
-3% -$175K ﹤0.01% 2677
2019
Q2
$5.92M Buy
344,600
+90,300
+36% +$1.46M ﹤0.01% 2489
2019
Q1
$4.09M Sell
254,300
-10,900
-4% -$177K ﹤0.01% 2688
2018
Q4
$3.88M Sell
265,200
-9,300
-3% -$148K ﹤0.01% 2588
2018
Q3
$4.99M Buy
274,500
+42,100
+18% +$737K ﹤0.01% 2707
2018
Q2
$3.92M Sell
232,400
-52,200
-18% -$987K ﹤0.01% 3030
2018
Q1
$5.58M Sell
284,600
-309,500
-52% -$5.99M ﹤0.01% 2413
2017
Q4
$12M Sell
594,100
-269,800
-31% -$4.96M ﹤0.01% 1679
2017
Q3
$15M Sell
863,900
-369,100
-30% -$5M 0.01% 1444
2017
Q2
$15.8M Buy
1,233,000
+247,000
+25% +$3.3M 0.01% 1330
2017
Q1
$12.8M Buy
986,000
+481,000
+95% +$6.08M 0.01% 1409
2016
Q4
$4.99M Buy
505,000
+24,400
+5% +$267K ﹤0.01% 2441
2016
Q3
$5.81M Buy
480,600
+12,300
+3% +$126K ﹤0.01% 2071
2016
Q2
$4.04M Sell
468,300
-204,000
-30% -$2.01M ﹤0.01% 2484
2016
Q1
$6.37M Buy
672,300
+47,100
+8% +$443K ﹤0.01% 2004
2015
Q4
$10.8M Sell
625,200
-10,600
-2% -$169K 0.01% 1672
2015
Q3
$8.54M Buy
635,800
+27,500
+5% +$552K ﹤0.01% 2012
2015
Q2
$13.7M Buy
608,300
+363,800
+149% +$6.39M 0.01% 1659
2015
Q1
$3.49M Sell
244,500
-106,900
-30% -$1.54M ﹤0.01% 3285
2014
Q4
$3.39M Sell
351,400
-477,900
-58% -$4.25M ﹤0.01% 3522
2014
Q3
$7.55M Buy
829,300
+18,900
+2% +$180K ﹤0.01% 2455
2014
Q2
$8.01M Buy
810,400
+410,400
+103% +$3.48M ﹤0.01% 2392
2014
Q1
$5.08M Sell
400,000
-96,000
-19% -$1.42M ﹤0.01% 2865
2013
Q4
$7.43M Buy
496,000
+8,500
+2% +$109K ﹤0.01% 2406
2013
Q3
$5.38M Buy
487,500
+123,900
+34% +$1.03M ﹤0.01% 2627
2013
Q2
$2.89M Buy
+363,600
New +$2.32M ﹤0.01% 3315

Other funds holding HALO

Susquehanna International Group's HALO Position: Q1 2026 in Review

Susquehanna International Group reduced its Halozyme (HALO) stake by 28% in Q1 2026, selling an estimated $1.21M and leaving 44,486 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #5351.

Susquehanna International Group first reported a position in HALO in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.4M in Q1 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Susquehanna International Group held 44,486 shares of Halozyme worth $2.88M as of Q1 2026.
  • Susquehanna International Group sold 17,220 Halozyme shares in Q1 2026, an estimated $1.21M.
  • Halozyme made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5351 holding.
  • Susquehanna International Group first reported a position in Halozyme in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Halozyme position peaked at $10.4M in Q1 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.